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The aims of the study were to assess whether C-reactive protein (CRP) is a sensitive marker for discriminating
between transudative and exudative and pleural eusions to evaluate whether it can be used to distinguish
inflammatory pleural eusions from other types of eusion.
Pleural fluid and serum CRP levels were obtained in 97 patients with pleural eusion, using an
immunoturbidimetric method (Olympus AU-600 autoanalyser). We compared CRP levels between transudates
and exudates, inflammatory eusions and other types of eusion.
According to the criteria used, 16 patients were included in the transudate group and 81 patients in the exudate
group. Pleural fluid CRP levels were significantly lower in the transudate group (P5004; 14949 mg l71 and
35549 mg l71 respectively). Also, the ratio of pleural fluid to serum was significantly lower in the transudate
group (P50009; 0805 mg l71 and 2807 mg l71, respectively). In the exudate group, 35 patients had
neoplastic eusions, 10 chronic non-specific pleurisy, 19 tuberculous pleurisy, 16 parapneumonic eusion and one
Dressler Syndrome. When these sub-groups were compared, the parapneumonic eusion subgroup CRP levels
(mean 89163 mg l71) were significantly higher than those in the other subgroups, other exudate of neoplastic
eusion, tuberculous pleurisy and chronic non-specific eusion and the transudate group (P500001; P500001;
P500004 and P500001, respectively). The ratio between pleural fluid and serum CRP was significantly higher in
the parapneumonic eusion subgroup than in the neoplastic subgroup ( P500002; 6627 mg l71 and 102 mg
l71, respectively). Pleural fluid CRP levels430 mg l71 had a high sensitivity (937%) and specificity (765 %) and a
positive predictive value of 984%. In the dierential diagnosis of pleural eusions, higher CRP levels may prove to
be a rapid, practical and accurate method of dierentiating parapneumonic eusions from other exudate types.
Although the high level of CRP obtained in the exudate group may be due to the number of patients with
parapneumonic eusion who were included, the pleural CRP level may also be helpful in discriminating between
exudative and transudative pleural eusions.
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Measurement of C-reactive protein (CRP) levels is a
clinically valuable screening test for organ disease, index
of disease activity and measure of response to therapy (1).
CRP levels have been shown to increase in a number of
pulmonary diseases, notably bacterial infection, inflamma-
tion, neoplasia, pulmonary thromboembolism and some
pleural eusions related to other conditions (1,2).
Assessing whether a pleural eusion is exudative or
transudative in nature is the first step in determining its
aetiology. Determining the cause of an exudative eusion isReceived 24 March 1999 and accepted in revised form 25
November 1999.
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0954-6111/00/050432+04 $35?00/0much more dicult than for a transudative eusion as CRP
levels increase significantly in inflammatory eusions.
We investigated the diagnostic usefulness of pleural
eusion CRP levels in the dierential diagnosis of
infectious pleural eusion and in discriminating exudative
from transudative eusions.
Materials and methods
We carried out a prospective study on 97 patients (69 men,
28 women) with pleural eusion who were admitted to
Atatu¨rk Chest Disease and Surgery Center between May
1996 and March 1997.
Fasting blood samples and pleural fluid samples were
obtained. The blood samples were centrifuged at 1500 g for
10 min. The pleural fluid samples were centrifuged at 2000 g
for 10 min to remove blood and other matter. The serum# 2000 HARCOURT PUBLISHERS LTD
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analysis.
The levels of glucose, total protein, albumin, lactic
dehydrogenase (LDH) and adenosine deaminase (ADA)
were measured in both sets of samples. Gram staining and
aerobic and anaerobic culture were performed on the pleural
eusion samples. To test for mycobacterium Ziehl Nielsen
staining was performed after homogenization, then the
samples were cultured in Loewenstein–Jansen culture media.
CRP analysis was performed on autoanalyser (Olympus
AU-600, Tokyo, Japan) using an immunoturbidimetric
method. The diagnostic reagent used for determination was
GmBH (Hamburg, Germany; Normal value 55 mg l71;
reference interval, 5–200 mg l71). According to the
literature accompanying the test kit, its use was appropriate
with both pleural and cerebrospinal fluid. The basic
principle of the test is that when the fluid sample is mixed
with the antiserum solution, the CRP reacts specifically
with anti-human CRP antibodies to yield insoluble
aggregates. The absorbance level of these aggregates is
proportional to the concentration of CRP in the sample.
The patients were divided into two groups, transudative
and exudative eusions using Light’s criteria (3). Briefly, if
one or more of the following criteria were present, the
pleural eusions were classified as exudative: pleural fluid
protein/serum protein ratio greater than 05; pleural fluid
LDH/serum LDH ratio greater than 06; pleural fluid LDH
greater than 200 IU l71. If the criteria were not met, the
eusion was classified as transudative.
The diagnosis of tuberculous pleurisy was made by
pleural biopsy and pleural fluid ADA levels of470 IU l71
were used to confirm this diagnosis. Criteria for the
diagnosis of parapneumonic eusions were: positive aero-
bic or anaerobic culture; positive Gram stain; presence of a
purulent eusion; white blood cell count of 5000–25 000;
and neutrophil predominance. Malignancy was confirmed
by a positive biopsy or cytology result. The one patient in
the study who was diagnosed with Dressler Syndrome had
experienced a myocardial infarction 3 weeks before
admission to our hospital. The eusion was an exudative
and the pathology report gave a diagnosis of non-specific
pleuritis. The biopsy results for 10 other patients wereTABLE 1. Pleural fluid C-reactive protein levels in the study grou
Transudative
eusion
Exudative
eusion
Malignant
eusion
Parapn
eu
Patients (n) 16 81 35 1
Mean 149 355 229 8
Median 10 22 11 6
SD 196 442 224 6
Minimum 1 1 1 2
Maximum 82 211 89 21
Data are given in mg l71chronic non-specific pleuritis (classified as the chronic non-
specific pleuritis subgroup).
Statistical analysis was conducted using the Mann–
Whitney U and Kruscal–Wallis tests.
Results
Of the study patients, 16 (164%) were included in the
transudative eusion group, while 81 (836%) were
included in the exudative eusion group. The exudative
eusion group was further divided into five subgroups
according to the diagnosis; parapneumonic eusions;
tuberculous eusions; malignant eusions; chronic non-
specific pleuritis; and Dressler Syndrome.
The distribution of the patients according to diagnosis
and the mean, median, minimum and maximum values are
given in Table 1 and Fig. 1.
Fluid CRP levels were significantly higher in exudative
than in the transudative eusion group (P5004). In
addition, the CRP levels in the parapneumonic eusion
subgroup were significantly higher than in the neo-
plastic subgroup (P500001), tuberculous pleurisy
subgroup (P500001), choronic non-specific pleurisy sub-
group (P500004) and the transudative eusion group
(P500001).
To determine the eciency of pleural fluid CRP
measurement in distinguishing exudative from transudative
eusions, we had originally considered using a cut-o value
of 30 mg l71. When this value was used, only two out of
the 16 transudative eusion patients were grouped in the
exudative eusion group. The sensitivity of the test was
937%, specificity 765%, and positive predictive value was
984%.
The ratio of pleural fluid to serum CRP was also
significantly higher in the exudative eusion group than in
the transudative eusion group (P50003). In addition,
this ratio was significantly lower in the neoplastic eusion
subgroup than in the parapneumonic eusion sub-group
(P500002)
Mean pleural CRP, serum CRP and pleural CRP/serum
CRP ratio values for all groups are given in Table 2.ps
eumonic
sion
Tuberculous
eusion
Chronic
non-specific pleuritis
Dressler
syndrome
6 19 10 1
9 26 128
4 11 65
52 292 14
2 2 1 26
1 96 35 26
FIG. 1. Pleural fluid C-reactive protein levels in eusions
secondary to transudative eusions, malignancy,
pneumonia, tuberculosis and Dressler Syndrome. Each
point represents one pleural fluid sample.
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In a living organism, a biochemical, physiological and
immunological reaction cascade is produced as a response
to chemical, physical and immunological stimuli, infectious
agents and malignancies. This reaction is known as the
acute phase response ( 4,5). CRP is an acute phase protein,
synthesized by the liver in response to various stimuli (5).
The induction of CRP synthesis is triggered by a number of
cytokines which are released in the inflammatory region,
chiefly the pirogenic cytokine, interleukin-6 (IL-6). The
sources of IL-6 are fibroblasts, lymphocytes, promyelocytes
and active macrophages (6,7).
CRP is thought to play an important role in inflamma-
tion, as it is seen to aggregate in the regions of inflammation
where its level increases by 3000-fold, however, its in vivo
function is not yet known. Two functions which have been
reported to date are activation of the compleman system
and recognition of molecules (8).
Classification of pleural eusions into transudative and
exudative eusions is currently based upon Light’s criteria
(8). However, as these groups include many subtypes, the
current classification does not solve the problem ofTABLE 2. Mean pleural CRP, serum CRP and pleural CRP/seru
Patient group n Pleural CRP level
Transudative eusion 16 14.94.9
Exudative eusion 81 35.54.9
Malignant eusion 35 22.83.7
Parapneumonic eusion 16 8916.3
Tuberculous eusion 19 266.7
Chronic non-specific pleuritis 10 12.84.4
Dressler Syndrome 1 26
Data are given in mg l71 as means SD.diagnosis. In order to achieve a specific diagnosis, especially
in the exudative eusion group, a more informative test is
needed. Until now, measurements including bilirubin,
cholesterol and ADA levels have been used with pleural
fluid, but with no definite success (9,10).
Recently, many reports have been written on the
biological use and the levels of CRP in numerous diseases,
but few have focused on CRP levels in patients with pleural
eusions (1,11,12). In this study, we aimed to assess the
value of CRP levels in the dierential diagnosis of exudate
type, especially in the parapneumonic eusion subgroup.
Vidriales et al. (1) reported that CRP levels were highly
elevated in inflammatory pleural eusions than in other
types of eusion. We have obtained similar results in our
study. They also reported that the pleural to serum CRP
ratio was significantly elevated in exudative eusions and
that this ratio was significantly lower in malignant eusions
then in parapneumonic and tuberculosis eusions (1).
Again, our findings confirm these results.
In our study, we found that serum CRP levels were
similar in parapneumonic eusion subgroup to those in the
other groups. Serum CRP levels are generally elevated in
infectious states, but usually do not consistent across all
bacteriaemic processes.
In tuberculous pleuritis, pleural eusion CRP levels are
lower than those of parapneumonic eusions but as an
indicator of inflammation they are higher than those found
in transudative eusions (1,13).
Nakano et al. measured IL-6 and CRP levels in pleural
eusions and serum from patients with mesothelioma,
adenocarcinoma and tuberculosis. They found that CRP
levels were similar in the mesothelioma and tuberculosis
groups. However, Vidriales et al. found that CRP levels
were twice as high in tuberculosis TB than in malignancy.
The high CRP level which we found in malignancy in our
study may have been due to the high number of
mesothelioma patients included in our malignant sub-
group and to the high levels of IL-6 found in malignant
mesothelioma (7). Vidriales et al. used 10 mg l71 as the cut-
o value in their study (1), but we found that the cut-o
value which yielded the best test performance was 30 mg
l71. We therefore used this level as the cut-o value.
In conclusion, pleural fluid CRP levels may be used to
discriminate parapneumonic eusions from other types ofm CRP ratio values in all patient groups
Serum CRP level Pleural CRP/serum CRP ratio
54.819.7 0.80.5
51.37.4 2.80.7
35.89.9 10.2
69.425.9 6.62.7
37.111.5 2.91.1
22.71.1 3.41.7
21 1.2
DIAGNOSIS OF PLEURAL EFFUSIONS 435exudative eusion and may be helpful in distinguishing
exudative from transudative eusions.
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